Silvercrest Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-636,589
Closed -$36.4M 844
2024
Q3
$36.4M Buy
636,589
+32,958
+5% +$1.89M 0.25% 128
2024
Q2
$31.6M Buy
603,631
+494
+0.1% +$21.7K 0.22% 140
2024
Q1
$24.5M Buy
603,137
+11,805
+2% +$443K 0.17% 163
2023
Q4
$21.9M Sell
591,332
-41,742
-7% -$1.57M 0.15% 167
2023
Q3
$24.2M Buy
633,074
+116,904
+23% +$4.79M 0.18% 156
2023
Q2
$18.6M Buy
516,170
+174,887
+51% +$5.97M 0.13% 179
2023
Q1
$13M Sell
341,283
-71,357
-17% -$3.35M 0.1% 200
2022
Q4
$23.5M Sell
412,640
-25,901
-6% -$1.33M 0.18% 148
2022
Q3
$17.3M Buy
438,541
+54,687
+14% +$2.42M 0.14% 171
2022
Q2
$16.9M Buy
383,854
+91,526
+31% +$3.96M 0.13% 185
2022
Q1
$11.7M Buy
292,328
+283,570
+3,238% +$10.1M 0.08% 233
2021
Q4
$352K Buy
8,758
+880
+11% +$32.9K ﹤0.01% 720
2021
Q3
$320K Buy
7,878
+918
+13% +$38.4K ﹤0.01% 746
2021
Q2
$316K Buy
6,960
+138
+2% +$6.11K ﹤0.01% 741
2021
Q1
$284K Buy
6,822
+221
+3% +$10.1K ﹤0.01% 754
2020
Q4
$282K Buy
+6,601
New +$237K ﹤0.01% 724

Other funds holding HALO

Silvercrest Asset Management's HALO Position: Q4 2024 in Review

Silvercrest Asset Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 636,589 shares — an estimated $36.4M sold.

Silvercrest Asset Management first reported a position in HALO in Q4 2020 and held it in 16 quarters. The position peaked at $36.4M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Silvercrest Asset Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 636,589 Halozyme shares in Q4 2024, an estimated $36.4M.
  • Silvercrest Asset Management first reported a position in Halozyme in Q4 2020 and held it in 16 quarters.
  • Silvercrest Asset Management's Halozyme position peaked at $36.4M in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Silvercrest Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.